Van Elle Holdings

Van Elle to take up to £4mln hit from Carillion’s downfall

Carillion owes Van Elle £1.6mln for past and ongoing contracts, while £2.5mln worth of work due to be completed over the next few months has also been thrown into doubt

London train station
Carillion is said to owe money to as many as 30,000 companies, including Van Elle

Investors in Van Elle Holdings PLC (LON:VANL) were rocked after the ground engineer said it stood to lose out on up to £4.1mln following the collapse of construction group Carillion PLC (LON:CLLN).

Van Elle carried out regular work for Carillion as a specialist sub-contractor, usually on contracts awarded by Network Rail, and the AIM-quoted firm undertook several jobs as recently as last month.

WATCH: Van Elle Holdings increasing profit and turnover year-on-year

The company estimates that it is owed around £1.6mln from those past contracts, some of which have carried over into the New Year.

With the sale of Carillion’s assets unlikely to cover all of the senior debts owed to the big banks, analysts don’t expect most of the smaller companies to see a penny.

Should that be the case for Van Elle, the firm has warned investors that there would be an “adverse financial impact” on the group.

On top of the money owed for past and ongoing jobs, Van Elle had £2.5mln worth of work lined up with Carillion between now and April – revenues which have now been thrown into doubt.

The company said it was too early to tell what the effect of Carillion’s demise will be on that contracted work, although it will monitor situation closely.

“While it is disappointing to note the Carillion announcement we continue to develop further our strong relationship with Network Rail and its principal contractors, and remain committed to developing high quality solutions in the rail division both for upgrade and maintenance work,” said chief executive Jon Fenton.

Van Elle shares slumped 9.4% to 87p in late-morning trade on Tuesday.

Quick facts: Van Elle Holdings

Price: £0.39

Market: AIM
Market Cap: £31.23 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Open Orphan 'driving research for novel drug development for rare diseases'

Proactive London sits down with Open Orphan PLC's (LON:ORPH) chief operating officer Maurice Treacy. Treacy discusses how he became involved with Open Orphan and his ambitions for the firm's health data initiative. ''Many rare diseases aren't known or badly diagnosed ... but rare isn't...

2 hours, 14 minutes ago


Result of AGM

4 days, 3 hours ago

Director/PDMR LTIP Awards

2 weeks, 6 days ago

Final Results

on 24/7/19

Trading Update

on 19/7/19

Directorate Change

on 8/5/19

2 min read